Wearable sensors track tiny movements in SMA babies on gene therapy
NCT ID NCT04833348
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 24 times
Summary
This study aims to better measure how well babies with spinal muscular atrophy (SMA) can move after receiving new treatments like gene therapy. Researchers will use small motion sensors on the babies' arms and legs to track changes in movement over time. The goal is to develop a more precise way to assess motor function in these infants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker-Enfants Malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.